Trevena, Inc.

About Trevena, Inc.

Trevena, Inc. is an innovative biopharmaceutical company focused on delivering groundbreaking medicines to address critical needs of patients with central nervous system (CNS) disorders.

Products & Services

OLINVYK (oliceridine) injection:An FDA-approved product in the United States for the treatment of acute pain, administered intravenously.

TRV045:An investigational drug candidate targeting S1P receptor for the treatment of diabetic neuropathic pain and epilepsy, currently in Phase 1, administered orally.

Specialties

Central Nervous System (CNS) disorders Innovative therapies Pain management Neuropathic pain treatment Migraine treatment Opioid use disorder treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Royalty Financing T: - FT: Royalty Financing	A: 2000000 MR: - FA: 2 million FAN: 2000000	D: 2024-07-08 FD: 2024-07-08	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2023-12-28 FD: 2023-12-28	-
3	RT: Private Placement T: - FT: Private Placement	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2023-12-27 FD: 2023-12-27	-
4	RT: Royalty-based T: - FT: Royalty-based	A: 15000000 MR: - FA: 15 million FAN: 15000000	D: 2023-09-06 FD: 2023-09-06	1 investors

Royalty Financing Latest

2024-07-08

$2.0M

1 investor (Pro only)

Private Placement 2023-12-28

$4.0M

Private Placement 2023-12-27

$4.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Trevena, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised